Frontline doctor to lead UK diabetes strategy
March 7, 2008Dr Rowan Hillson has been appointed the new national clinical director for diabetes. Dr Hillson is a consultant physician and …
NICE’s approach to benefits and costs to be reviewed
March 7, 2008Sales and Marketing
The pharmaceutical industry has welcomed plans to review how NICE assesses the benefits and costs of drugs, with the hope …
Diabetes nurses would cut emergency admissions
March 7, 2008Sales and Marketing
Specialist nurses could help to cut the number of diabetes patients being admitted to hospital as emergency cases, a new …
Latest news from Datamonitor
March 5, 2008Sales and Marketing
APP Pharma granted approval for generic anticancer drug APP Pharmaceuticals has received final approval from the FDA of its abbreviated …
Government remains tight-lipped on PPRS
February 29, 2008Sales and Marketing par
The Department of Health has refused to comment on renewed speculation on the future of the UK's medicines pricing system …
FDA rejects long-acting version of Zyprexa
February 29, 2008Sales and Marketing
Lilly has suffered a setback after the US medicines regulator rejected a new version of its top-selling product Zyprexa. The …
Working with NICE: the ingredients for success
February 29, 2008Research and Development, Sales and Marketing NICE, healthcare, industry relations, pharma
NICE fascinates everyone in the industry, and NICE knows only too well that every move it makes is studied by …
Avastin receives surprise FDA approval
February 29, 2008Sales and Marketing
The FDA gone against the advice of its own advisory panel to approve Genentech's Avastin as a first-line treatment for …
AstraZeneca fined $200m over Medicaid pricing
February 29, 2008Sales and Marketing
A US court has ruled AstraZeneca must pay more than $200 million for inflating the prices of drugs prescribed under …
Latest news from Datamonitor
February 28, 2008Sales and Marketing
Algeta to initiate US clinical trials for prostate cancer drug Cancer therapeutics company Algeta has said that it will commence …
GlaxoSmithKline’s Tyverb poised for launch in the UK
February 27, 2008Research and Development
GlaxoSmithKline says its new breast cancer drug Tyverb is ready for launch and could be prescribed to the first UK …
Health comms agency Hive launched
February 27, 2008Medical Communications
A group of experienced healthcare communications executives have launched Hive which they claim represents a 'next generation' of agency to …
Boehringer Ingelheim’s anti-clotting pill ready for launch
February 15, 2008Research and Development
Boehringer Ingelheim's Pradaxa is expected to gain final regulatory approval shortly and could make a major impact in the anti-thrombosis …
Latest news from Datamonitor
February 15, 2008Research and Development
Introgen and Moffitt initiate Phase II lung cancer trial Introgen Therapeutics and Moffitt Cancer Center have reported that a randomized, …
Generics and Avandia decline will hold GSK back
February 8, 2008Sales and Marketing
GlaxoSmithKline's chief executive-in-waiting Andrew Witty faces a difficult first year at the helm of the company after sales growth was …
Vectibix launched for bowel cancer in UK
February 8, 2008Sales and Marketing colorectal cancer
Vectibix, a new treatment for advanced colorectal cancer, has been launched in the UK. The treatment from Amgen was first …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
